23and me stock.
All Those 23andMe Spit Tests Were Part of a Bigger Plan. CEO Anne Wojcicki wants to make drugs using insights from millions of customer DNA samples, and doesn’t think that should bother anyone ...
23andMe Holding Third Quarter 2023 ResultsKey Financial Results. Revenue: US$66.9m (up 18% from 3Q 2022). Net loss: US$92.0m (loss widened by 2.9% from 3Q 2022). US$0.20 loss per share.By Bret Kenwell, InvestorPlace Contributor Aug 11, 2022, 3:12 pm EST. 23andMe ( ME) stock has more than doubled so far this month, with shares up 127% at today’s high from the July 29 low ...Nov 27, 2023 · 2 Wall Street research analysts have issued 1-year price objectives for 23andMe's shares. Their ME share price targets range from $1.75 to $7.00. On average, they anticipate the company's stock price to reach $4.38 in the next year. This suggests a possible upside of 381.4% from the stock's current price. Nov 29, 2023 · What is 23andMe's consensus rating and price target? According to the issued ratings of 1 analysts in the last year, the consensus rating for 23andMe stock is Buy based on the current 1 buy rating for ME. The average twelve-month price prediction for 23andMe is $1.75 with a high price target of $1.75 and a low price target of $1.75.
23andMe has raised $877.69M over 26 rounds. 23andMe's latest funding round was a Corporate Minority - P2P for $51M on January 18, 2022. 23andMe's valuation in June 2021 was $3,500M. Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.Establishing ownership of stock depends on how the stock was purchased, according to the Securities and Exchange Commission. A brokerage firm may have purchased the stock or it may have been bought directly from the company.ME Earnings Date and Information. 23andMe last announced its earnings results on November 8th, 2023. The reported ($0.16) EPS for the quarter. The company had revenue of $50 million for the quarter, compared to analyst estimates of $56.80 million. 23andMe has generated ($0.73) earnings per share over the last year ( ($0.73) diluted earnings per ...
Website. 2006. 758. Anne Wojcicki. https://www.23andme.com. 23andMe Holding Co. operates as a consumer genetics testing company. The company operates in two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on …
4 de fev. de 2021 ... SirRichardBranson #23andMe #SPAC Virgin Group Founder Sir Richard Branson and 23andMe CEO & Co-Founder Annew Wojcicki join Yahoo Finance to ...The 23andMe Holding stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention. ME. +10.27%. DNA-testing company 23andMe confirmed Monday that information about 6.9 million people, about half of its 14 million customers, was accessed …Published: Dec. 1, 2023 at 6:36 p.m. ET. By Sabela Ojea. 23andMe it expects to book $1 million to $2 million in costs related to a cybersecurity breach reported in October. The …ME. +10.27%. DNA-testing company 23andMe confirmed Monday that information about 6.9 million people, about half of its 14 million customers, was accessed …
23andMe Holding Co. is the leading direct-to-consumer genetic testing company entering drug development with data on 11.3M Genotyped Customers and +$696M in SPAC funding.
Achieved FY2023 financial guidance FY2023 full year revenue grew 10% over prior year Webcast today, May 25, 2023 at 4:30 p.m. Eastern Time SOUTH SAN FRANCISCO, Calif., May 25, 2023 (GLOBE NEWSWIRE ...
The average price point forecasted by analysts for 23andMe Holding Co (ME) is $3.30, which is $2.44 above the current market price. The public float for ME is 269.01M, and currently, short sellers hold a 10.00% ratio of that floaft. The average trading volume of ME on November 21, 2023 was 3.42M shares. ME) stock’s […]Created with Highstock 2.1.8. 23andMe Holding Co. Annual stock financials by MarketWatch. View the latest ME financial statements, income statements and financial ratios.Real stock prices are not the same as the last traded stock price. Real stock prices are adjustments to closing stock prices. The adjustments are used in a variety of ways, including dividends, the range of prices and the closing price of t...r/MEstock: Welcome to this forum of 23&me for independent investors. 23andMe Announces Updated Safety and Preliminary Efficacy Data From the Phase 1/2a Study of 23ME-00610, an Investigational Antibody Targeting CD200R1 Industry. Biotechnology. No executives to display. Corporate headquarters. --, --. Find real-time ME - 23andMe Holding Co. stock quotes, company profile, news and forecasts from CNN Business.ME stock looks attractively valued. 23andMe has an EV (enterprise value) of around $4.2 billion and is expected to generate revenues of $400 million in 2024, which would mean a 2024 EV-to-sales ...
Nov 30, 2023 · A. The latest price target for 23andMe Holding ( NASDAQ: ME) was reported by Citigroup on Thursday, August 10, 2023. The analyst firm set a price target for 1.75 expecting ME to rise to within 12 ... 23andMe saw a increase in short interest in October. As of October 31st, there was short interest totaling 26,900,000 shares, an increase of 0.4% from the previous total of 26,800,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price ...ME Earnings Date and Information. 23andMe last announced its earnings results on November 8th, 2023. The reported ($0.16) EPS for the quarter. The company had revenue of $50 million for the quarter, compared to analyst estimates of $56.80 million. 23andMe has generated ($0.73) earnings per share over the last year ( ($0.73) diluted …Nov 30, 2023 · A. The latest price target for 23andMe Holding ( NASDAQ: ME) was reported by Citigroup on Thursday, August 10, 2023. The analyst firm set a price target for 1.75 expecting ME to rise to within 12 ... Website. 2006. 758. Anne Wojcicki. https://www.23andme.com. 23andMe Holding Co. operates as a consumer genetics testing company. The company operates in two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers’ genetic ...25 de set. de 2023 ... Anne Wojcicki and her co-founders started 23andMe back in 2006 with a clear mission: to make genetic testing and its results, ...In early October 2023, user data misappropriated in the incident appeared for sale on a hacking forum, including information from "one million 23andMe users of Jewish Ashkenazi descent and 100,000 ...
November 16, 2023. $0.76. 3,664,420. 1:1. $0.86. $0.86. $0.75. NOTE: The Closing Price, Day's High, Day's Low, and Day's Volume have been adjusted to account for any stock …Analyst Report: 23andMe Holding Co. 23andMe is a consumer-facing healthcare technology company, primarily involved in the sale of direct-to-consumer personal genome services, or PGS, through DNA ...
23andMe co-founder and CEO Anne Wojcicki sees a much bigger presence for her DNA decoding company in the pharma space. "The end of the GSK collaboration comes in July, and it opens up all kinds of ...Funding. 23andMe has raised a total of. $1.1B. in funding over 19 rounds. Their latest funding was raised on Jun 17, 2021 from a Post-IPO Equity round. 23andMe is registered under the ticker NASDAQ:ME . 23andMe is funded by 39 investors. Richard Branson and Altimeter Capital are the most recent investors. 23andMe has a post-money valuation in ...FY2023 Financial Guidance. 23andMe is raising its full year guidance following Q3 FY2023 results. Full year revenue for fiscal year 2023, which will end on March 31, 2023, is projected to be in the range of $290 to $300 million, with a net loss in the range of $325 to $335 million. The full year Adjusted EBITDA deficit is projected to be in the ...Genetic testing company 23andMe announced on Friday that hackers accessed around 14,000 customer accounts in the company’s recent data breach. …23andMe shares surge 21% in their trading debut after merger with Richard Branson-backed SPAC Last Updated: June 19, 2021 at 1:17 p.m. ET First Published: June 17, 2021 at 2:14 p.m. ETSee 23andMe Holding Co. (ME) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. We found 2 solutions for 23and Me's Stock And Trade. The top solutions are determined by popularity, ratings and frequency of searches. The most likely answer for the clue is BARTER. How many solutions does 23and Me's Stock And Trade have? With crossword-solver.io you will find 16 solutions. We use historic puzzles to find the best …Shares of 23andMe Holding ( ME 3.64%) stock slipped in Friday morning trading after the genetic data miner announced that it will spend $400 million to acquire on-demand online medical care and ...Scores. ME has an Altman Z-Score of -2.3 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy. Altman Z-Score. -2.3. Piotroski F-Score. 3. Detailed statistics for 23andMe Holding Co. (ME) stock, including valuation metrics, financial numbers, share information and more.14 de nov. de 2023 ... 23andMe Holding Co. (NASDAQ: ME), the genetic screening company that went public via a SPAC in 2021, received a deficiency letter from the ...
23andMe price target lowered to $3 from $5 at TD Cowen November 9, 2023TipRanks. Analysts Conflicted on These Healthcare Names: Sana Biotechnology (SANA), 23andMe Holding (ME) and Invitae (NVTA ...
Historical daily share price chart and data for 23andMe Holding since 2020 adjusted for splits and dividends. The latest closing stock price for 23andMe Holding as of November …
Establishing ownership of stock depends on how the stock was purchased, according to the Securities and Exchange Commission. A brokerage firm may have purchased the stock or it may have been bought directly from the company.Find the latest 23andMe Holding Co. (ME) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.4 de fev. de 2021 ... SirRichardBranson #23andMe #SPAC Virgin Group Founder Sir Richard Branson and 23andMe CEO & Co-Founder Annew Wojcicki join Yahoo Finance to ...November 16, 2023. $0.76. 3,664,420. 1:1. $0.86. $0.86. $0.75. NOTE: The Closing Price, Day's High, Day's Low, and Day's Volume have been adjusted to account for any stock …Product details. 23andMe health + ancestry personal genetic service includes ancestry service plus more than 85 DNA-based online reports on health predispositions, carrier status, wellness & traits with just one test. Health predisposition reports show how genetics can impact your chances of developing certain health conditions, including ...23andMe, Inc. SUNNYVALE, Calif., Jan. 27, 2022 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (“23andMe”), a leading consumer genetics and research company, announced today that it will ...17 de jun. de 2021 ... 23andMe is now listed on the Nasdaq stock exchange as $ME! As a public company, we have the opportunity to expand on our mission and have an ...Discover historical prices for ME stock on Yahoo Finance. View daily, weekly or monthly format back to when 23andMe Holding Co. stock was issued. ME Earnings Date and Information. 23andMe last announced its earnings results on November 8th, 2023. The reported ($0.16) EPS for the quarter. The company had revenue of $50 million for the quarter, compared to analyst estimates of $56.80 million. 23andMe has generated ($0.73) earnings per share over the last year ( ($0.73) diluted …Discover historical prices for ME stock on Yahoo Finance. View daily, weekly or monthly format back to when 23andMe Holding Co. stock was issued. Analyst Report: 23andMe Holding Co. 23andMe is a consumer-facing healthcare technology company, primarily involved in the sale of direct-to-consumer personal genome services, or PGS, through DNA ... 23andMe Holding Co. analyst ratings, historical stock prices, earnings estimates & actuals. ME updated stock price target summary.
USD$129 USD$79. See how your DNA breaks out across 2750+ regions worldwide with the most comprehensive ancestry breakdown on the market. Discover relatives from near and far with our DNA Relative Finder. Share reports with family and friends. Learn how your DNA influences your facial features, taste, smell and other traits.r/MEstock: Welcome to this forum of 23&me for independent investors. 23andMe Announces Updated Safety and Preliminary Efficacy Data From the Phase 1/2a Study of 23ME-00610, an Investigational Antibody Targeting CD200R1 r/MEstock: Welcome to this forum of 23&me for independent investors. 23andMe Announces Updated Safety and Preliminary Efficacy Data From the Phase 1/2a Study of 23ME-00610, an Investigational Antibody Targeting CD200R1If you’re just getting started, tracking investments might seem like a mystery. Thankfully, modern tools and technology make it easier than ever to figure out how to manage your stock portfolio and to track it. This quick guide gives you ti...Instagram:https://instagram. best ira for cryptodiscount futures tradingis usda a conventional loanus corp bank 23andMe will host a conference call at 4:30 p.m. Eastern Time on Thursday, May 26th, 2022 to discuss the financial results for the full year and Q4 FY2022 and report on business progress. ... non-cash stock-based compensation expense, acquisition-related costs, litigation settlements not related to normal and continued business activities, and ... eeft stockwho are the big three automakers Analyst Report: 23andMe Holding Co. 23andMe is a consumer-facing healthcare technology company, primarily involved in the sale of direct-to-consumer personal genome services, or PGS, through DNA ... Future criteria checks 1/6. 23andMe Holding's earnings are forecast to decline at 1.6% per annum while its annual revenue is expected to grow at 12.1% per year. EPS is expected to grow by 0.4% per annum. Return on equity is forecast to be … how can you tell if gold is real at home Power to Investors. A high-level overview of 23andMe Holding Co. (ME) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, …23andMe is a genomics and biotechnology company that provides health reports to consumers by analyzing their DNA. The company's services include the analysis of one's genome for ancestry breakdown ...